AUA annual meeting featured the 4 th annual IBCG Bladder Cancer Forum evaluating common problems and controversies in bladder cancer, moderated by Dr. Bernard Bochner, with a debate between Drs. Sia ...

The pre-analytical workflow is one of the primary considerations in the successful use of liquid biopsies for cancer ...

In a study from Dr. Zlotta’s group published in 2025 in the Journal of Urology, 1 they suggest that better tools are needed to minimize interobserver variability in pathological grading. This is ...

Updated findings from a phase 2 study investigating the IL-2–binding monoclonal antibody AU-007 show a manageable safety ...

When it comes to men’s health, prostate cancer is one of those topics that many shy away from, but it’s too important to ignore. ContentsProstate Cancer?Causes of Prostate CancerStages of Prostate ...

The sun beats down mercilessly – the once-cooling island breeze barely offering relief. The ocean, our source of pride and sustenance, shimmers under the heat, yet beneath its beauty, a ...

Pancreatic cancer happens when normal cells in the pancreas change into abnormal cells and grow out of control. The pancre­as is an organ that sits be­hind the stomach. It makes hormones and juices ...

Learn about dismissed symptoms that might indicate serious medical conditions requiring immediate surgical intervention and ...

Q1 2025 Earnings Conference Call April 29, 2025 6:45 AM ETCompany ParticipantsAndy Barnett - Head of IRPascal Soriot ...

Cretostimogene grenadenorepvec is an investigational oncolytic immunotherapy that is being studied for the treatment of bladder cancer, particularly non-muscle invasive bladder cancer (NMIBC) that is ...

TAR-200 showed high complete response rates in BCG-unresponsive, high-risk non-muscle invasive bladder cancer with CIS in the ...